Inhibition of collagen-induced arthritis in mice by viral il-10 gene transfer

Journal of Immunology

Volumn 161, Issue 3, 1998, Pages 1516-1524

  Ma, Yuhe ^a   Thornton, Sherry ^a   Duwel, Laura E ^a   Boivin, Gregory P ^a   Giannini, Edward H ^a   Leiden, Jeffrey M ^b   Bluestone, Jeffrey A ^b   Hirsch, Raphael ^a,c  

^a UNIVERSITY OF CINCINNATI   (United States)

^b UNIVERSITY OF CHICAGO   (United States)

^c CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

RECOMBINANT INTERLEUKIN 10;

ANIMAL CELL; ANIMAL TISSUE; ARTHRITIS; ARTICLE; AUTOIMMUNITY; CELL PROLIFERATION; COLLAGEN SYNTHESIS; CYTOKINE PRODUCTION; DISEASE SEVERITY; DRUG DELIVERY SYSTEM; GENE TRANSFER; HISTOPATHOLOGY; IMMUNOSUPPRESSIVE TREATMENT; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ADENOVIRIDAE; ANIMALS; ARTHRITIS, EXPERIMENTAL; COLLAGEN; CYTOKINES; FREUND'S ADJUVANT; GENE TRANSFER TECHNIQUES; GENETIC VECTORS; IMMUNOGLOBULIN G; INCIDENCE; INJECTIONS, INTRA-ARTICULAR; INJECTIONS, INTRAVENOUS; INTERLEUKIN-10; KNEE JOINT; LYMPHOCYTE ACTIVATION; MALE; MICE; MICE, INBRED DBA; RNA, MESSENGER; TIME FACTORS;

EID: 0032146169     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (60)

1. Koch, A. E., S. L. Kunkel, and R. M. Strieter. 1995. Cytokines in rheumatoid arthritis. J. Invest. Med. 43:28.
2. Brennan, F. M., R. N. Maini, and M. Feldmann. 1992. TNF-α: a pivotal role in rheumatoid arthritis? Br. J. Rheum. 31:293.
3. Mosmann, T. R., and R. L. Coffman. 1989. TH1 and TH2 cells: Different patterns of lymphokine secretion lead to different functional properties. Annu. Rev. Immunol. 7:145.
4. Gajewski, T. F., S. R. Schell, G. Nau, and F. W. Fitch. 1989. Regulation of T cell activation: differences among T cell subsets. Immunol. Rev. 111:79.
5. Marcelletti, J. F., J. Ohara, and D. H. Katz. 1991. Collagen-induced arthritis in mice: relationship of collagen-specific and total IgE synthesis to disease. J. Immunol. 147:4185.
6. Quayle, A. J., P. Chomarat, P. Miossec, J. Kjeldsen-Kragh, O. Forre, and J. B. Natvig. 1993. Rheumatoid inflammatory T-cell clones express mostly Th1 but also Th2 and mixed (Th0-like) cytokine patterns. Scand. J. Immunol. 38:75.
7. Miltenburg, A. M. M., J. M. Van Laar, R. D. Kuiper, M. R. Daha, and F. C. Breedveld. 1992. T cell clones from human rheumatoid synovial membrane functionally represent the TH1 subset. Scand. J. Immunol. 35:603.
8. Mauritz, N. J., R. Holmdahl, R. Honsson, P. H. van der Meide, A. Scheynius, and L. Klareskog. 1988. Treatment with γ-IFN triggers the onset of collagen arthritis in mice. Arthritis Rheum. 31:1297.
9. Fiorentino, D. F., M. W. Bond, and T. R. Mosmann. 1989. Two types of mouse T helper cells. IV. Th2 clones secrete a factor that inhibits cytokine production by Th1 clones. J. Exp. Med. 170:2081.
10. Walmsley, M., P. D. Katsikis, E. Abney, S. Parry, R. O. Williams, R. N. Maini, and M. Feldmann. 1996. Interleukin-10 inhibition of the progression of established collagen-induced arthritis. Arthritis Rheum. 39:495.
11. Kasama, T., R. M. Stricter, N. W. Lukacs, P. M. Lincoln, M. D. Burdick, and S. L. Kunkel. 1995. Interleukin-10 expression and chemokine regulation during the evolution of murine type II col lagen-induced arthritis. J. Clin. Invest. 95: 2868.
12. Joosten, L. A. B., E. Lubberts, P. Durez, M. M. A. Helsen, M. J. M. Jacobs, M. Goldman, and W. B. van den Berg. 1997. Role of interleukin-4 and interleukin-10 in murine collagen-induced arthritis: protective effect of interleukin-4 and interleukin-10 treatment on cartilage destruction. Arthritis Rheum. 40:249.
13. Katsikis, P. D., C. Q. Chu, F. M. Brennan, R. N. Maini, and M. Feldmann. 1994. Immunoregulatory role of interleukin-10 in rheumatoid arthritis. J. Exp. Med. 179:1517.
14. Cush, J. J., J. B. Splawski, R. Thomas, J. E. McFarlin, H. Schulze-Koops, L. S. Davis, K. Fujita, and P. E. Lipsky. 1995. Elevated interleukin-10 levels in patients with rheumatoid arthritis. Arthritis Rheum. 38:96.
15. Del Prete, G., M. De Carli, F. Almerigogna, M. G. Gindizi, R. Biagiotti, and S. Romagnani. 1993. Human IL-10 is produced by both type 1 helper (Th1) and type 2 helper (Th2) T cell clones and inhibits their antigen-specific proliferation and cytokine production. J. Immunol. 150:353.
16. de Waal-Malefyt, R., J. Haanen, H. Spits, M. G. Roncarolo, A. te Velde, C. Figdor, K. Johnson, R. Kastelein, H. Yssel, and J. E. de Vries. 1991. Interleukin 10 (IL-10) and viral IL-10 strongly reduce antigen-specific human T cell proliferation by diminishing the antigen-presenting capacity of monocytes via downregulation of class II major histocompatibility complex expression. J. Exp. Med. 174:915.
17. de Waal-Malefyt, R., J. Abrams, B. Bennett, C. G. Figdor, and J. E. de Vries. 1991. Interleukin 10 (IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes. J. Exp. Med. 174:1209.
18. Moore, K. W., P. Vieira, D. F. Fiorentino, M. L. Trounstine, T. A. Khan, and T. R. Mosmann. 1990. Homology of cytokine synthesis inhibitory factor (IL-10) to the Epstein-Barr virus gene BCRF1. Science 248:1230.
19. Baer, R., A. T. Bankier, M. D. Biggin, P. L. Deininger, P. J. Farrell, T. J. Gibson, G. Hatfull, G. S. Hudson, S. C. Satchwell, C. Seguin, P. S. Tuffnell, and B. G. Barrell. 1984. DNA sequence and expression of the B95-8 Epstein-Barr virus genome. Nature 310:207.
20. MacNeil, I. A., T. Suda, K. W. Moore, T. R. Mosmann, and A. Zlotnik. 1990. IL-10, a novel growth cofactor for mature and immature T cells. J. Immunol. 145:4167.
21. Go, N. F., B. E. Castle, R. Barrett, R. Kastelein, W. Dang, T. R. Mosmann, K. W. Moore, and M. Howard. 1990. Interleukin 10, a novel B cell stimulatory factor: unresponsiveness of X chromosome-linked immunodeficiency B cells, J. Exp. Med. 172:1625.
22. de Waal Malefyt, R., J. Haanen, H. Spits, M. G. Roncarolo, A. te Velde, C. Figdor, K. Johnson. R. Kastelein, H. Yssel, and J. E. de Vries. 1991. Interleukin 10 (IL-10) and viral IL-10 strongly reduce antigen-specific human T cell proliferation by diminishing the antigen-presenting capacity of monocytes via downregulation of class II major histocompatibility complex expression. J. Exp. Med. 174:915.
23. de Waal Malefyt, R., J. Abrams, B. Bennett, C. G. Figdor, and J. E. de Vries. 1991. Interleukin 10 (IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes. J. Exp. Med. 174:1209.
24. Drazan, K. E., L. Wu, D. Bullington, and A. Shaken. 1996. Viral IL-10 gene therapy inhibits TNF-α and IL-1β, not IL-6, in the newborn endotoxemic mouse. J. Pediatr. Surg. 31:411.
25. Qin, L., K. D. Chavin, Y. Ding, J. P. Favaro, J. E. Woodward, J. Lin, H. Tahara, P. Robbins, A. Snaked, D. Y. Ho, R. M. Sapolsky, M. T. Lotze, and J. S. Bromberg. 1995. Multiple vectors effectively achieve gene transfer in a murine cardiac transplantation model. Transplantation 59:809.
26. Suzuki, T., H. Tahara, S. Narula, K. W. Moore, P. D. Robbins, and M. T. Lotze. 1995. Viral interleukin 10 (IL-10), the human herpes virus 4 cellular IL-10 homologue, induces local anergy to allogeneic and syngeneic tumors. J. Exp. Med. 182:477.
27. Stuart, J. M., A. S. Townes, and A. H. Kang. 1982. Nature and specificity of the immune response to collagen in type II collagen-induced arthritis in mice. J. Clin. Invest. 69:673.
28. Courtenay, J. S., M. J. Dallman, A. D. Dayan, A. Martin, and B. Mosedale. 1980. Immunisation against heterologous type II collagen induces arthritis in mice. Nature 283:666.
29. Graham, F., and A. Van Der Eb. 1973. A new technique for the assay of infectivity of human adenovirus 5 DNA. Virology 52:446.
30. Graham, F. L., J. Smiley, W. C. Russell, and R. Nairn. 1977. Characteristics of a human cell line transformed by DNA from human adenovirus type 5. J. Gen. Virol. 36:59.
31. Hughes, C., J. A. Wolos, E. H. Giannini, and R. Hirsch. 1994. Induction of T cell anergy in an experimental model of autoimmunity using non-mitogenic anti-CD3 mAb. J. Immunol. 153:3319.
32. Sawchuk, S. J., G. P. Boivin, L. Duwel, W. Ball, B. Trapnell, K. Bove, and R. Hirsch. 1996. Anti-TCR mAb prolongs transgene expression following adeno viral-mediated in vivo gene transfer to mouse synovium. Hum. Gene Ther. 7:499.
33. Leo, O., M. Foo, D. H. Sachs, L. E. Samelson, and J. A. Bluestone. 1987. Identification of a mAb specific for a murine T3 polypeptide. Proc. Natl. Acad. Sci. USA 84:1374.
34. Ginsberg, H. S., L. L. Moldawer, P. B. Sehgal, M. Redington, P. L. Kilian, R. M. Chanock, and G. A. Prince. 1991. A mouse model for investigating the molecular pathogenesis of adenovirus pneumonia. Proc. Natl. Acad. Sci. USA 88:1651.
35. Rawle, F. C., A. E. Tollefson, W. S. M. Wold, and L. R. Gooding. 1989. Mouse anti-adenovirus CTL. Inhibition of lysis by E3 pg19K but not E3 14.7K. J. Immunol. 143:2031.
36. Dai, Y., E. M. Schwarz, D. Gu, W. Zhang, N. Sarvetnick, and I. M. Verma. 1995. Cellular and humoral immune responses to adenoviral vectors containing factor IX gene: tolerization of factor IX and vector antigens allows for long-term expression. Proc. Natl. Acad. Sci. USA 92:1401.
37. Yang, Y., F. A. Nunes, K. Berencsi, E. E. Furth, E. Gonczol, and J. M. Wilson. 1994. Cellular immunity to viral antigens limits E1-deleted adenovirus for gene therapy. Proc. Natl. Acad. Sci. USA 91:4407.
38. Zsengeller, Z. K., S. E. Wert, W. M. Hull, X. Hu, S. Yei, B. C. Trapnell, and J. A. Whitsett. 1995. Persistence of replication-deficient adenovirus-mediated gene transfer in lungs of immune-deficient (nu/nu) mice. Hum. Gene Ther. 6:457.
39. Engelhardt, J. F., X. Ye, B. Doranz, and J. M. Wilson. 1994. Ablation of E2A in recombinant adenoviruses improves transgene persistence and decreases inflammatory responses in mouse liver. Proc. Natl. Acad. Sci. USA 91:6196.
40. Kolls, J. K., D. Lei, G. Odom, S. Nelson, W. R. Summer, M. A. Gerber, and J. E. Shellito. 1996. Use of transient CD4 lymphocyte depletion to prolong transgene expression of E1-deleted adenoviral vectors. Hum. Gene Ther. 7:489.
41. Huard, J., H. Lochmuller, G. Acsadi, A. Jani, B. Massie, and G. Karpati. 1995. The route of administration is a major determinant of the transduction efficiency of rat tissues by adenoviral recombinants. Gene Ther. 2:107.
42. Yang, Y., C. Hildegund, C. J. Ertl, and J. M. Wilson. 1994. MHC class I-restricted CTL to viral antigens destroy hepatocytes in mice infected with E1-deleted recombinant adenoviruses. Immunity 1:433.
43. + CTLs in vivo. J. Immunol. 155:2564.
44. Bakker, A. C., L. A. B. Joosten, O. J. Arntz, M. M. A. Helsen, A. M. Bendele, F. A. J. van de Loo, and W. B. van den Berg. 1997. Prevention of murine collagen-induced arthritis in the knee and ipsilateral paw by local expression of human interleukin-1 receptor antagonist protein in the knee. Arthritis Rheum. 40:893.
45. Geiger, T., H. Towbin, A. Cosenti-Vargas, O. Zingel, J. Arnold, C. Rordorf, M. Glatt, and K. Vosbeck. 1993. Neutralization of interleukin-1β activity in vivo with a mAb alleviates collagen-induced arthritis in DBA/1 mice and prevents the associated acute-phase response. Clin. Exp. Rheum. 11:515.
46. Wooley, P. H., J. D. Wbalen, D. L. Chapman, A. E. Berger, K. A. Richard, D. G. Aspar, and N. D. Staite. 1993. The effect of an interleukin-1 receptor antagonist protein on type 11 collagen-induced arthritis and antigen-induced arthritis in mice. Arthritis Rheum. 36:1305.
47. Joosten, L. A. B., M. M. A. Helsen, F. A. J. van de Loo, and W. B. van den Berg. 1994. Amelioration of established collagen-induced arthritis (CIA) with anti-IL-1. Agents Actions 41:C174.
48. Tanaka, Y., T. Otsuka, T. Hotokebuchi, H. Miyahara, H. Nakashima, S. Kuga, Y. Nemoto, H. Niiro, and Y. Niho. 1996. Effect of IL-10 on collagen-induced arthritis in mice. Inflamm. Res. 45:283.
49. Moreland, L. W., S. W. Baumgartner, M. H. Schiff, E. A. Tindall, R. M. Fleischmann, A. L. Weaver, R. E. Ettlinger, S. Cohen, W. J. Koopman, K. Mohler, M. B. Widmer, and C. M. Blosch. 1997. Treatment of rheumatoid arthritis with a recombinant human TNF receptor (p75)-Fc fusion protein. N. Engl. J. Med. 337:141.
50. Elliot, M. J., R. N. Maini, M. Feldmann, A. Long-Fox, P. Charles, P. Katsikis, F. M. Brennan, J. Walker, H. Bijl, J. Ghrayeb, and J. N. Woody. 1993. Treatment of rheumatoid arthritis with chimeric monoclonal antibodies to TNF-α. Arthritis Rheum. 36:1681.
51. Bresnihan, B., L. Lookabaugh, K. Witt, and P. Musikic. 1996. Treatment with recombinant human interieukin-1 receptor antagonist (rhIL-1ra) in rheumatoid arthritis (RA): result of a randomized double-blind, placebo controlled multi-center trial. Arthritis Rheum. 39:S73 (Abstr.)
52. Wan, I., and M. Cobby. 1996. Recombinant human IL-1 receptor antagonist (rhIL-1ra) reduces the rate of joint erosion in rheumatoid arthritis (RA). Arthritis Rheum. 39:S123.
53. Bessis, N., M. Boissier, P. Ferrara, T. Blankenstein, D. Fradelizi, and C. Foumier. 1996. Attenuation of collagen-induced arthritis in mice by treatment with vector cells engineered to secrete interleukin-13. Eur. J. Immunol. 26:2399.
54. van de Loo, A. A. J., and W. B. van den Berg. 1990. Effects of murine recombinant interleukin 1 on synovial joints in mice: measurement of patellar cartilage metabolism and joint inflammation. Ann. Rheum. Dis. 49:238.
55. Bandara, G., G. M. Mueller, J. Galea-Lauri, M. H. Tindal, H. I. Georgescu, M. K. Suchanek, G. L. Hung, J. C. Glorioso, P. D. Robbins, and C. H. Evans. 1993. Intraarticular expression of biologically active interleukin 1-receptor- antagonist protein by ex vivo gene transfer. Proc. Natl. Acad. Sci, USA 90: 10764.
56. Roessler, B. J., J. W. Hartman, D. K. Vallance, J. M. Latta, S. L. Janich, and B. L. Davidson. 1995. Inhibition of interleukin-1 -induced effects in synoviocytes transduced with the human IL-1 receptor antagonist cDNA using an adenoviral vector. Hum. Gene Ther. 6:307.
57. Makarov, S. S., J. C. Olsen, W. N. Johnston, S. K. Anderle, R. R. Brown, A. S. Baldwin, J. S. Haskill, and J. H. Schwab. 1996. Suppression of experimental arthritis by gene transfer of interleukin 1 receptor antagonist cDNA. Proc. Natl. Acad. Sci. USA 93:402.
58. Zhang, H., Y. Yang, J. L. Horton, E. B. Samoilova, T. A. Judge, L. A. Turka, J. M. Wilson, and Y. Chen. 1997. Amelioration of collagen-induced arthritis by CD95(Apo-1/Fas)-ligand gene transfer. J. Clin. Invest. 100:1951.
59. Le, C. H., A. G. Nicolson, A. Morales, and K. L. Sewell. 1997. Suppression of collagen-induced arthritis through ade no virus-mediated transfer of a modified TNF α receptor gene. Arthritis Rheum. 40:1662.
60. Qin, L., Y. Ding, D. R. Pahud, N. D. Robson, A. Shaked, and J. S. Bromberg. 1997. Adenovirus-mediated gene transfer of viral interleukin-10 inhibits the immune response to both alloantigen and adenoviral antigen. Hum. Gene Ther. 8:1365.